Abstract
Background/purpose of the study
The HbA1c test was officially introduced by the American Diabetes Association (ADA) as a diagnostic and monitoring tool for diabetes mellitus in 2010.The following year, the World Health Organization (WHO) decided to accept the use of this test for similar reasons. The HbA1c test reflects average plasma glucose over the proceeding 8 to 12 weeks. Therefore, this test should ideally be performed every 2 to 3 months. The HbA1c value can be inaccurate with certain comorbidities such as hemoglobinopathies, high turnover of erythrocytes, and following blood transfusion. In developing countries, HbA1c tests are quite expensive so its demand must be appropriate. This study aims to evaluate the early HbA1c test, which was performed in less than 3 months, and its association with the incidence of hemoglobinopathies in the Dr. Saiful Anwar Hospital.
Methods
This is a retrospective study using historical data from the Laboratory Information System (LIS) in the period of 2012 until 2017.
Results
Over 5 years, there were 32,000 HbA1c tests. About 18% were repeated more than two times in less than 3 months. Of this number, 6.4% was performed in less than a month, 5.9% in 1 to 2 months, and 5.7% in 2 to 3 months.
Conclusion
This may not only be caused by the lack of communication between clinicians and laboratory personnel, but also the presence of hemoglobinopathies, causing unreliable results. Requesting HbA1c test too early can result in inaccurate measurements. As a consequence, there is a need for better communication between clinicians and laboratory personnel.
Similar content being viewed by others
References
Salinas M, López‐Garrigós M, Flores E, Leiva‐Salinas C, Tests PGotAUoL, Valero VP, et al. Glycated hemoglobin: a powerful tool not used enough in primary care. J Clin Lab Anal. 2018;32(3):e22310.
Akan P, Cimrin D, Ormen M, Kume T, Ozkaya A, Ergor G, et al. The inappropriate use of HbA1c testing to monitor glycemia: is there evidence in laboratory data? J Eval Clin Pract. 2007;13(1):21–4.
Hanna FW, Geen J, Issa BG, Tahrani AA, Fryer AA. Limitations of glycosylated haemoglobin (HbA1c) in diabetes screening. Pract Diabetes. 2012;29(1):29–31.
Owora AH. Diagnostic validity and clinical utility of HbA1c tests for type 2 diabetes mellitus. Curr Diabetes Rev. 2018;14(2):196.
Kim H-J, Choi EY, Park EW, Cheong YS, Lee H-Y, Kim JH. The utility of HbA1c as a diagnostic criterion of diabetes. Kor J Fam Med. 2011;32(7):383.
Nadkarni P, Weinstock RS. Chapter 16: Carbohydrates. In: McPherson RA, Pincus MR. Henry’s clinical diagnosis and management by laboratory methods. 23rd Edition. St. Louis, Missouri. Elsevier Health Sciences; 2017. p 209.
Khan MAH, Rabeya MR, Saiedullah M. Measurements of HbA1c by high performance liquid chromatography in D-10 analyzer and immunological method by Beckman Coulter AU480 System: a comparative study. J Enam Med Coll. 2012;2(2):62–6.
Drugs CAf, Health Ti. HbA1c testing frequency: a review of the clinical evidence and guidelines: Canadian Agency for Drugs and Technology in Health; 2015.
Driskell OJ, Holland D, Hanna FW, Jones PW, Pemberton RJ, Tran M, et al. Inappropriate requests for glycated hemoglobin (HbA1c) are widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability. Clin Chem. 2012:clinchem. 2011.176487.
Driskell OJ, Holland D, Waldron JL, Ford C, Scargill JJ, Heald A, et al. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control. Diabetes Care. 2014;37(10):2731–7.
Kilpatrick ES, Atkin SL. Using haemoglobin A1c to diagnose type 2 diabetes or to identify people at high risk of diabetes. Bmj. 2014;348:g2867.
Sehrawat T, Jindal A, Kohli P, Thour A, Kaur J, Sachdev A, et al. Utility and limitations of glycated hemoglobin (HbA1c) in patients with liver cirrhosis as compared with oral glucose tolerance test for diagnosis of diabetes. Diabetes Ther. 2018;9(1):243–51.
Hellman R. When are HBA1C values misleading? AACE Clin Case Rep. 2016;2(4):e377–9.
Amin Mohsin Z, Paul A, Devendra S. Pitfalls of using HbA1c in the diagnosis and monitoring of diabetes. London J Prim Care. 2015;7(4):66–9.
Thevarajah M, Nadzimah M, Chew Y. Interference of hemoglobinA1c (HbA1c) detection using ion-exchange high performance liquid chromatography (HPLC) method by clinically silent hemoglobin variant in University Malaya Medical Centre (UMMC)—a case report. Clin Biochem. 2009;42(4–5):430–4.
Bilgin S, Aktas G, Kurtkulagi O, Atak BM, Duman TT. Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects. J Diabetes Metab Disord. 2020;19:511–4.
Kocak MZ, Aktas G, Atak BM, Duman TT, Yis OM, Erkus E, et al. Is neuregulin‐4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Investig. 2020;50(3):e13206.
Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2019;1–5.
Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–6.
Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 2019;65(1):38–42.
Bilgin S, Aktas G, Zahid Kocak M, Atak BM, Kurtkulagi O, Duman TT, et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male. 2019;1–5.
Erkus E, Aktas G, Kocak MZ, Duman TT, Atak BM, Savli H. Diabetic regulation of subjects with type 2 diabetes mellitus is associated with serum vitamin D levels. Rev Assoc Med Bras. 2019;65(1):51–5.
Aggarwal V, Schneider AL, Selvin E. Low hemoglobin A1c in nondiabetic adults: an elevated risk state? Diabetes Care. 2012;35(10):2055–60.
Carson AP, Fox CS, McGuire DK, Levitan EB, Laclaustra M, Mann DM, et al. Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ: Cardiovasc Qual Outcomes. 2010;3(6):661–7.
Christman AL, Lazo M, Clark JM, Selvin E. Low glycated hemoglobin and liver disease in the US population. Diabetes Care. 2011;34(12):2548–50.
McCoy RG, Van Houten HK, Ross JS, Montori VM, Shah ND. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001–13: observational population based study. Bmj. 2015;351:h6138.
Acknowledgments
We would like to thank the Dean of Medical Faculty of Universitas Brawijaya and Direktorat Jendral of Research, Technology and Higher Education of Indonesia, Saiful Anwar General Hospital of Malang, East Java and our colleagues from Department of Child Health, Faculty of Medicine, Universitas Brawijaya.
Funding
This study is supported by Wynacom Unitama Sejahtera Company and dr. Saiful Anwar General Hospital.
Author information
Authors and Affiliations
Contributions
All authors have contributed to this study.
Corresponding author
Ethics declarations
Ethics approval
The study was conducted according to the Declaration of Helsinki and was approved by the ethics committee of our institution.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Widijanti, A., Aprilia, A., Sutrisnani, C.S. et al. Evaluation of the prevalence of inappropriate hba1c examination requests at the General Hospital of Dokter Saiful Anwar Malang. Int J Diabetes Dev Ctries 42, 560–564 (2022). https://doi.org/10.1007/s13410-021-00996-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-021-00996-8